359 related articles for article (PubMed ID: 24454930)
21. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
[TBL] [Abstract][Full Text] [Related]
22. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
[TBL] [Abstract][Full Text] [Related]
23. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
[TBL] [Abstract][Full Text] [Related]
25. NLRP3 inflammasome function and pyroptotic cell death in human placental Hofbauer cells.
Abrahams VM; Tang Z; Mor G; Guller S
J Reprod Immunol; 2020 Nov; 142():103214. PubMed ID: 33152658
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells.
Xie Q; Shen WW; Zhong J; Huang C; Zhang L; Li J
Int J Mol Med; 2014 Jul; 34(1):341-9. PubMed ID: 24789624
[TBL] [Abstract][Full Text] [Related]
27. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells.
Kuhny M; Hochdörfer T; Ayata CK; Idzko M; Huber M
Cell Commun Signal; 2014 Jul; 12():40. PubMed ID: 25184735
[TBL] [Abstract][Full Text] [Related]
28. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
[TBL] [Abstract][Full Text] [Related]
29. Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies.
Leu WJ; Chu JC; Hsu JL; Du CM; Jiang YH; Hsu LC; Huang WJ; Guh JH
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339319
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.
Kahlenberg JM; Carmona-Rivera C; Smith CK; Kaplan MJ
J Immunol; 2013 Feb; 190(3):1217-26. PubMed ID: 23267025
[TBL] [Abstract][Full Text] [Related]
31. Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.
Suzuki K; Murakami T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
Int Immunol; 2011 Mar; 23(3):185-93. PubMed ID: 21393634
[TBL] [Abstract][Full Text] [Related]
32. Chicken cathelicidin-2 promotes NLRP3 inflammasome activation in macrophages.
Peng L; Tian H; Lu Y; Jia K; Ran J; Tao Q; Li G; Wan C; Ye C; Veldhuizen EJA; Chen H; Fang R
Vet Res; 2022 Sep; 53(1):69. PubMed ID: 36064470
[TBL] [Abstract][Full Text] [Related]
33. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria.
Franchi L; Kanneganti TD; Dubyak GR; Núñez G
J Biol Chem; 2007 Jun; 282(26):18810-8. PubMed ID: 17491021
[TBL] [Abstract][Full Text] [Related]
34. Ginsenosides enhance P2X7-dependent cytokine secretion from LPS-primed rodent macrophages.
Dhuna K; Helliwell R; De Luca SN; Spencer SJ; Stokes L
Purinergic Signal; 2024 Feb; 20(1):65-71. PubMed ID: 37055674
[TBL] [Abstract][Full Text] [Related]
35. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
He Y; Franchi L; Núñez G
J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
[TBL] [Abstract][Full Text] [Related]
36. The
Jakka P; Namani S; Murugan S; Rai N; Radhakrishnan G
J Biol Chem; 2017 Dec; 292(50):20613-20627. PubMed ID: 29061850
[TBL] [Abstract][Full Text] [Related]
37. P2Y
Thorstenberg ML; Martins MDA; Figliuolo V; Silva CLM; Savio LEB; Coutinho-Silva R
Mediators Inflamm; 2020; 2020():2545682. PubMed ID: 33061823
[TBL] [Abstract][Full Text] [Related]
38. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
39. ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols.
Nuka E; Ohnishi K; Terao J; Kawai Y
PLoS One; 2018; 13(9):e0204229. PubMed ID: 30248132
[TBL] [Abstract][Full Text] [Related]
40. Sera from Septic Patients Contain the Inhibiting Activity of the Extracellular ATP-Dependent Inflammasome Pathway.
Ho VM; Hirohashi N; Kong WS; Yun G; Ota K; Itai J; Yamaga S; Suzuki K; Tanigawa K; Kanno M; Shime N
Tohoku J Exp Med; 2018 Jul; 245(3):193-204. PubMed ID: 30033950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
